Quest to divest HemoCue diagnostic biz for about $300 million

02/25/2013 | RTT News

Radiometer Medical has agreed to acquire Quest Diagnostics' HemoCue business for about $300 million, plus cash balance adjustments, in a deal set to be finalized next month. HemoCue focuses on developing and marketing point-of-care diagnostics, including those used in glucose and hemoglobin testing.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC